Cargando…
Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer
Lung cancer is the first leading cause of cancer deaths worldwide. Non‐small cell lung cancer (NSCLC) is the most common type of lung cancer. Increasing evidence shows that long noncoding RNA (lncRNA) are capable of modulating tumor initiation, proliferation and metastasis. In the present study, we...
Autores principales: | Xie, Yujiao, Zhang, Yi, Du, Lutao, Jiang, Xiumei, Yan, Suzhen, Duan, Weili, Li, Juan, Zhan, Yao, Wang, Lili, Zhang, Shujun, Li, Shuhai, Wang, Lishui, Xu, Shuo, Wang, Chuanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928376/ https://www.ncbi.nlm.nih.gov/pubmed/29504701 http://dx.doi.org/10.1002/1878-0261.12188 |
Ejemplares similares
-
Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma
por: Yan, Suzhen, et al.
Publicado: (2020) -
Overexpression of long noncoding RNA NORAD in colorectal cancer associates with tumor progression
por: Wang, Lili, et al.
Publicado: (2018) -
Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer
por: Jiang, Xiumei, et al.
Publicado: (2017) -
Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer
por: Zhan, Yao, et al.
Publicado: (2018) -
Evaluation of serum exosomal LncRNA‐based biomarker panel for diagnosis and recurrence prediction of bladder cancer
por: Zhang, Shujun, et al.
Publicado: (2018)